Consensus results of the Delphi panel for delivery and follow-up
| Statement . | Agreement % (n/N) . |
|---|---|
| Hb levels targeted before delivery should be decided on a case-by-case basis‡ | 41.7 (5/12) |
| The Hb level that should be targeted before delivery would not differ between a vaginal delivery or a cesarean section, assuming that all other variables are the same† | 75.0 (9/12) |
| If a pregnant patient with SCD who was not on prophylactic transfusion therapy during pregnancy needed transfusion before delivery, ST would be preferred over other transfusion modalities (ie, mRBCx [modified/partial] or aRBCx)‡ | 66.7 (8/12) |
| In the absence of maternal and/or fetal complications, spontaneous labor should be awaited up to 40 weeks of gestation‡ | 58.3 (7/12) |
| In the absence of maternal and/or fetal complications, labor should be induced or a cesarean section should be planned at 36 to 38 weeks of gestation‡ | 50.0 (6/12) |
| A decision for labor induction or an elective cesarean section for pregnant individuals with SCD should be made by a multidisciplinary team, including OB/GYN specialists, hematologists, neonatologists, anesthesiologists, and blood bank specialists∗ | 91.7 (11/12) |
| Besides the standard obstetric indications, there are no SCD-specific indications for electing a cesarean section over a vaginal delivery for pregnant individuals with SCD† | 83.3 (10/12) |
| Statement . | Agreement % (n/N) . |
|---|---|
| Hb levels targeted before delivery should be decided on a case-by-case basis‡ | 41.7 (5/12) |
| The Hb level that should be targeted before delivery would not differ between a vaginal delivery or a cesarean section, assuming that all other variables are the same† | 75.0 (9/12) |
| If a pregnant patient with SCD who was not on prophylactic transfusion therapy during pregnancy needed transfusion before delivery, ST would be preferred over other transfusion modalities (ie, mRBCx [modified/partial] or aRBCx)‡ | 66.7 (8/12) |
| In the absence of maternal and/or fetal complications, spontaneous labor should be awaited up to 40 weeks of gestation‡ | 58.3 (7/12) |
| In the absence of maternal and/or fetal complications, labor should be induced or a cesarean section should be planned at 36 to 38 weeks of gestation‡ | 50.0 (6/12) |
| A decision for labor induction or an elective cesarean section for pregnant individuals with SCD should be made by a multidisciplinary team, including OB/GYN specialists, hematologists, neonatologists, anesthesiologists, and blood bank specialists∗ | 91.7 (11/12) |
| Besides the standard obstetric indications, there are no SCD-specific indications for electing a cesarean section over a vaginal delivery for pregnant individuals with SCD† | 83.3 (10/12) |